ITCH inhibits alkaliptosis in human pancreatic cancer cells through YAP1-dependent SLC16A1 activation
The International Journal of Biochemistry & Cell Biology · 2024
DOI: 10.1016/j.biocel.2024.106646 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2024. Verfasst von Xiutao Cai und 6 weiteren Autor:innen. Beteiligte Einrichtung: DAMP Laboratory, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510150, China; Guangzhou Municipal and Guangdong P…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, YAP-Signaling Proteins, Ubiquitin-Protein Ligases, Transcription Factors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Alkaliptosis is a type of pH-dependent cell death and plays an emerging role in tumor suppression. However, the key modulation mechanism of alkaliptosis remains largely unknown. In particular, the nucleus, as the centre of genetic and metabolic regulation, is crucial for the regulation of cellular life. It is not known whether nuclear proteins are involved in the regulation of alkaliptosis. Here, we isolated nuclear proteins to perform a proteomics that identified itchy E3 ubiquitin protein ligase (ITCH) as a natural inhibitor of alkaliptosis in human pancreatic ductal adenocarcinoma (PDAC) cells. The downregulation of ITCH protein is associated with the induction of alkaliptosis in three human PDAC cell lines (SW1990, MiaPaCa2, and PANC1). Functionally, increasing ITCH expression reduces JTC801-induced growth inhibition and cell death. In contrast, knocking down ITCH using specific shRNA increases JTC801-induced cell growth inhibition in the short or long term, resulting in increased cell death. Mechanistically, JTC801-induced ITCH inhibition blocks large tumor suppressor kinase 1 (LATS1) ubiquitination, which in turn suppresses Yes1 associated transcriptional regulator (YAP1)-dependent the transcriptional activation of solute carrier family 16 member 1 (SLC16A1), a proton-linked monocarboxylate transporter that inhibits JTC801-induced alkaliptosis. Additionally, decreased expression of ITCH is associated with longer survival times in patients with PDAC. Collectively, our results establish an ITCH-dependent pathway that regulates alkaliptotic sensitivity in PDAC cells and deepen the understanding of alkaliptosis in targeted therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- DAMP Laboratory, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510150, China; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, Guan…
- Department of Surgery, UT Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Surgery, UT Southwestern Medical Center, Dallas, TX 75390, USA.. Electronic address: daolin.tang@utsouthwestern.edu.
Zitieren
APA
Cai, X., Chen, F., Tang, H., Chao, D., Kang, R., Tang, D., & Liu, J. (2024). ITCH inhibits alkaliptosis in human pancreatic cancer cells through YAP1-dependent SLC16A1 activation. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2024.106646
Vancouver
Cai X, Chen F, Tang H, Chao D, Kang R, Tang D, et al. ITCH inhibits alkaliptosis in human pancreatic cancer cells through YAP1-dependent SLC16A1 activation. The International Journal of Biochemistry & Cell Biology. 2024. doi:10.1016/j.biocel.2024.106646
BibTeX
@article{Cai2024,
author = {Cai, Xiutao and Chen, Fangquan and Tang, Hu and Chao, Dandan and Kang, Rui and Tang, Daolin and Liu, Jiao},
title = {ITCH inhibits alkaliptosis in human pancreatic cancer cells through YAP1-dependent SLC16A1 activation},
journal = {The International Journal of Biochemistry & Cell Biology},
year = {2024},
doi = {10.1016/j.biocel.2024.106646}
}
EUVIMED